Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Bifidobacterium pseudosmall chain ccfm1046, its composition, fermented food, use, bacterial agent and preparation method of bacterial agent

A bifidobacteria and fermented food technology, applied in the field of microorganisms, can solve problems such as irritation of the gastrointestinal tract, liver function damage, and impact on patients, and achieve the effects of relieving weight gain, improving weight gain, and reducing Parkinson's disease

Active Publication Date: 2021-12-17
JIANGNAN UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These drugs have a good curative effect on each single risk factor of metabolic syndrome. However, long-term use of drugs has certain side effects. For example, long-term use of metformin can cause irritation to the gastrointestinal tract of some patients and cause discomfort and may affect the patient’s response to vitamin B12. The absorption of rosiglitazone can cause liver function damage and edema, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bifidobacterium pseudosmall chain ccfm1046, its composition, fermented food, use, bacterial agent and preparation method of bacterial agent
  • Bifidobacterium pseudosmall chain ccfm1046, its composition, fermented food, use, bacterial agent and preparation method of bacterial agent
  • Bifidobacterium pseudosmall chain ccfm1046, its composition, fermented food, use, bacterial agent and preparation method of bacterial agent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0083] Example 1: Pseudo-small chain Bifidobacterium CCFM1046 has good tolerance to simulated gastrointestinal fluid

[0084] Inoculate the cryopreserved Pseudomonas bifidobacterium CCFM1046 in mMRS medium (MRS medium + 0.05% cysteine ​​hydrochloride), culture anaerobically at 37°C for 48 hours, and then subculture in mMRS medium for 2 After ~3 times, take 1mL of the culture solution of Bifidobacterium pseudospermia CCFM1046, mix it with 9.0mL of pH 2.5 artificial simulated gastric juice (mMRS medium containing 1% pepsin, pH=2.5), and anaerobically For culture, samples were taken at 0h, 0.5h, 1h and 2h respectively, poured and cultured with mMRS agar medium to count plate colonies, determine the number of viable bacteria and calculate their survival rate.

[0085] The survival rate is the ratio of the logarithmic value of the number of viable bacteria at the time of sampling to the logarithmic value of the number of viable bacteria at the 0th hour in the culture solution, expr...

Embodiment 2

[0090] Example 2: Bifidobacterium pseudosmall-chain CCFM1046 has no toxic or side effects on C57BL / 6J mice Bifidobacterium pseudo-small-chain CCFM1046 cells were resuspended in 3% sucrose solution to make a concentration of 3.0×10 8 CFU / mL bacterial suspension. Six healthy male C57BL / 6J mice with a body weight of about 20 g were taken. After one week of adaptation to the environment, the bacterial suspension of this concentration was administered orally once a day, observed for one week, and the death and body weight were recorded.

[0091] The results of these tests are listed in Table 3. These results indicate that feeding concentrations of 3.0×10 8 The CFU / mL pseudosmall chain Bifidobacterium CCFM1046 had no significant impact on the mice, no significant change in body weight, and no death. The appearance of the mice had no obvious pathological symptoms.

[0092] Table 3 Changes in body weight and death of mice

[0093]

[0094]

[0095] Note: -: no death of mice ...

Embodiment 3

[0096] Example 3: Pseudomonas bifidobacterium CCFM1046 has a recovery effect on the intestinal flora imbalance caused by high-fat feed

[0097] 36 healthy male C57BL / 6J mice weighing 18-20 g were taken, adapted to the environment for 1 week, and randomly divided into 6 groups: blank control group (NC), high-fat model control group (HFD), simvastatin control group (SC ), the rosiglitazone control group (RH), the Bifidobacterium pseudobacterium CCFM1046 intervention group (CCFM1046), the Bifidobacterium animalis BB12 control group (BB12), each group contained 6 mice, and the bacteria suspension The dose is 3.0 x 10 8 CFU / mL, resuspended in 3% sucrose solution. The grouping and treatment methods of experimental animals are shown in Table 4:

[0098] Table 4 Grouping of experimental animals

[0099]

[0100] The body weight of the mice was monitored regularly during the experiment.

[0101] At the end of the experiment, the fresh feces of the mice were collected and frozen ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses bifidobacterium pseudosmall chain CCFM1046, its composition, fermented food, application, bacterial agent and preparation method thereof. Bifidobacterium pseudosmall chain CCFM1046 can tolerate human gastrointestinal environment and significantly improve high-fat diet The resulting increase in liver triglyceride content in mice with metabolic syndrome; alleviated weight gain in mice with metabolic syndrome; significantly improved fasting blood glucose and abnormal oral glucose tolerance in mice with metabolic syndrome, and reduced the area under the curve of glucose tolerance drugs. Improve serum insulin levels; significantly improve the serum low-density lipoprotein cholesterol level in mice with metabolic syndrome caused by high-fat diet; significantly improve the increase in intestinal Proteus caused by high-fat diet, used to prepare and relieve metabolic syndrome The medicinal composition and fermented food that reduce Parkinson's disease, intestinal infection, urinary tract, kidney infection and other diseases have very broad application prospects.

Description

technical field [0001] The invention belongs to the technical field of microorganisms, and in particular relates to pseudosmall chain bifidobacterium CCFM1046, its composition, fermented food, application, bacterial agent and preparation method thereof. Background technique [0002] In recent years, with the continuous development of our country's social and economic level, the living standards of the public have continued to improve, the proportion of carbohydrates and fats in the diet structure has increased day by day, and the restrictions of many working conditions have made it easy for people to develop sedentary behavior Habit. These external environmental factors combined with their own genetic factors have led to the continuous increase in the incidence of metabolic syndrome in the Chinese population. According to reports, between 2002 and 2010, the proportion of people over the age of 20 in my country with metabolic syndrome rose from 5.4% to 21.3%, an increase of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N1/20A61K35/745A61P3/06A61P3/10A61P1/16A61P25/16A61P31/00A23C9/123A23C13/16A23C19/032A23L11/50A23L11/60A23L33/00C12R1/01
CPCC12N1/20A61K35/745A61P3/06A61P3/10A61P1/16A61P25/16A61P31/00A23C9/1234A23C13/16A23C19/0323A23C11/106A23L33/00A61K2035/115A23V2002/00A23L11/50C12R2001/01C12N1/205A23V2400/535A23V2200/3204A23V2200/3262A23V2200/328A23V2200/32A23V2200/322A23V2200/30
Inventor 陈卫王刚刘煜飞赵建新张灏
Owner JIANGNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com